Tag: multiomics market overview

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Multiomics Market from 2024 to 2033?
The multiomics market has rapidly expanded, expected to rise from $2.78 billion in 2023 to $3.27 billion in 2024, with a CAGR of 17.7%. This growth is driven by increased biomedical research, government funding, chronic disease prevalence, technological advancements, and improved data analysis tools.

The multiomics market is projected to see rapid growth, expected to reach $6.28 billion by 2028 at a CAGR of 17.8%. Growth drivers include advances in AI and clinical applications. Major trends include new commercial platforms, spatially resolved analysis, and expansion into clinical diagnostics.

Claim Your Free Sample of the Global Multiomics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Key Factors Are Fueling the Growth of the Multiomics Market?
The growing need for personalized medicine is anticipated to drive the expansion of the multiomics market in the future. Personalized medicine involves customizing healthcare decisions and treatments based on individual patients’ genetic, environmental, and lifestyle factors. This trend is fueled by technological advancements, a rising demand for targeted therapies, and improvements in global healthcare. Multiomics contributes to personalized medicine by offering a comprehensive understanding of an individual’s genetic, molecular, and metabolic profiles, allowing healthcare providers to customize treatments accordingly. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, a rise from 6 approvals in 2022. Thus, the increasing demand for personalized medicine is propelling the multiomics market.

What Are the Major Segments of the Multiomics Market?
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

What New Trends Are Transforming the Multiomics Market?
Companies in the multiomics market are creating single-cell multiomics platforms for large-scale biological studies. In February 2023, Becton, Dickinson, and Company launched the BD Rhapsody HT Xpress, a platform that allows analysis of single cells with high throughput.

Order Now for Fast Delivery of Your Multiomics Market Report!
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Regions Are Driving Growth in the Multiomics Market?
North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Multiomics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the multiomics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Multiomics Market Include

1. Multiomics Market Executive Summary
2. Multiomics Market Segments
3. Multiomics Market Size And Template Market Growth Rate
4.  Key Multiomics Market Trends
5. Major Multiomics Market Drivers
……
25. Key Mergers And Acquisitions In The Multiomics Market
26. Top Multiomics Companies
27. Multiomics Market Opportunities And Strategies
28. Multiomics Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Multidrug Resistant Bacteria Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

Multimode-Fiber Cable Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Multiomics Global Market Report 2024, the multiomics market is expected to show significant growth in the forecast period.

• Market Size Surge: The multiomics market has witnessed significant growth, expanding from $2.78 billion in 2023 to $3.27 billion in 2024, with a compound annual growth rate (CAGR) of 17.7%.
• Historical Drivers: This surge can be attributed to increased biomedical research, enhanced funding from both government and private sectors, rising prevalence of chronic diseases, technological advancements, and improved computational tools for data analysis.

Continued Expansion Predicted for the Future

• Forecasted Growth: The market is expected to continue its upward trajectory, reaching $6.28 billion by 2028, with a CAGR of 17.8%.
• Growth Factors: Key contributors to this future growth include advancements in artificial intelligence (AI) and machine learning (ML), expansion of clinical applications, the growing biopharmaceutical industry, the emergence of integrated multiomics platforms, and increasing applications in agricultural and environmental research.

Major Trends Shaping the Market

• Technological Advancements: Continuous technological innovations and the launch of new commercial multiomics platforms are driving the market forward.
• Spatially Resolved Multiomics: The adoption of spatially resolved multiomics analysis is gaining traction, particularly in biopharmaceutical research and development.
• Clinical Diagnostics Expansion: The application of multiomics in clinical diagnostics is expanding, further fueling market growth.

View More On The Multiomics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Personalized Medicine: A Key Market Driver

• Rising Demand: The growing demand for personalized medicine, which tailors healthcare treatments to individual patients based on their genetic, environmental, and lifestyle factors, is a major driver of the multiomics market.
• Technological Contributions: Multiomics provides a detailed understanding of an individual’s genetic, molecular, and metabolic profile, allowing healthcare providers to customize treatments.
• Industry Impact: For example, in 2023, the FDA approved 16 novel personalized therapies for rare diseases, a significant increase from 6 in 2022, demonstrating the rising importance of personalized medicine.

Key Players in the Multiomics Market

• Leading Companies: Major companies in the multiomics market include Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., and others.
• Innovation Focus: These companies are continuously innovating, developing advanced platforms and expanding their capabilities to stay competitive in the rapidly growing market.

Innovative Single-Cell Multiomics Platforms Transforming Research

• Single-Cell Advancements: Single-cell multiomics platforms are at the forefront of innovation, allowing researchers to conduct large-scale studies with high sample integrity.
• Example: Becton, Dickinson, and Company’s BD Rhapsody HT Xpress, launched in February 2023, exemplifies this innovation. This high-throughput platform allows for the isolation, barcoding, and analysis of single cells with greater efficiency and flexibility, enhancing research outcomes.

Strategic Acquisitions Strengthen Market Position

• Notable Acquisition: In October 2022, Clinical Microbiomics acquired MS-Omics, bolstering its capabilities in microbiome analysis and solidifying its leadership in the field.
• Comprehensive Solutions: This acquisition enables Clinical Microbiomics to offer a comprehensive suite of multiomics solutions, providing deeper insights into the role of the microbiome in health and disease.

Market Segmentation and Regional Insights

• Segmentation: The multiomics market is segmented by type (Single-Cell Multiomics, Bulk Multiomics), platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Other Applications), and end user (Academics and Research Organizations, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Other End-Users).
• Regional Analysis: North America was the largest region in the multiomics market in 2023, while Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Request A Sample Of The Global Multiomics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15866&type=smp